These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 37452432)

  • 1. Chloroquine Intervenes Nephrotoxicity of Nilotinib through Deubiquitinase USP13-Mediated Stabilization of Bcl-XL.
    Yan H; Huang X; Xu J; Zhang Y; Chen J; Xu Z; Li H; Wang Z; Yang X; Yang B; He Q; Luo P
    Adv Sci (Weinh); 2023 Sep; 10(26):e2302002. PubMed ID: 37452432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of PI3K/mTOR overcomes nilotinib resistance in BCR-ABL1 positive leukemia cells through translational down-regulation of MDM2.
    Ding J; Romani J; Zaborski M; MacLeod RA; Nagel S; Drexler HG; Quentmeier H
    PLoS One; 2013; 8(12):e83510. PubMed ID: 24349524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BH3 mimetics in combination with nilotinib or ponatinib represent a promising therapeutic strategy in blast phase chronic myeloid leukemia.
    Parry N; Busch C; Aßmann V; Cassels J; Hair A; Helgason GV; Wheadon H; Copland M
    Cell Death Discov; 2022 Nov; 8(1):457. PubMed ID: 36379918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of Quercetin-Induced Apoptosis by Cotreatment with Autophagy Inhibitor Is Associated with Augmentation of BAK-Dependent Mitochondrial Pathway in Jurkat T Cells.
    Ha EJ; Kim KY; Kim CE; Jun DY; Kim YH
    Oxid Med Cell Longev; 2019; 2019():7989276. PubMed ID: 31827702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nilotinib.
    Quintás-Cardama A; Kim TD; Cataldo V; le Coutre P
    Recent Results Cancer Res; 2010; 184():103-17. PubMed ID: 20072834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The deubiquitinase (DUB) USP13 promotes Mcl-1 stabilisation in cervical cancer.
    Morgan EL; Patterson MR; Barba-Moreno D; Scarth JA; Wilson A; Macdonald A
    Oncogene; 2021 Mar; 40(11):2112-2129. PubMed ID: 33627786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nilotinib induces apoptosis and autophagic cell death of activated hepatic stellate cells via inhibition of histone deacetylases.
    Shaker ME; Ghani A; Shiha GE; Ibrahim TM; Mehal WZ
    Biochim Biophys Acta; 2013 Aug; 1833(8):1992-2003. PubMed ID: 23499874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bcl-xL augmentation potentially reduces ischemia/reperfusion induced proximal and distal tubular apoptosis and autophagy.
    Chien CT; Shyue SK; Lai MK
    Transplantation; 2007 Nov; 84(9):1183-90. PubMed ID: 17998875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic effects of p53 activation via MDM2 inhibition in combination with inhibition of Bcl-2 or Bcr-Abl in CD34+ proliferating and quiescent chronic myeloid leukemia blast crisis cells.
    Carter BZ; Mak PY; Mak DH; Ruvolo VR; Schober W; McQueen T; Cortes J; Kantarjian HM; Champlin RE; Konopleva M; Andreeff M
    Oncotarget; 2015 Oct; 6(31):30487-99. PubMed ID: 26431162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin enhances the cytotoxic effect of nilotinib and overcomes nilotinib resistance in chronic myeloid leukemia cells.
    Na YJ; Yu ES; Kim DS; Lee DH; Oh SC; Choi CW
    Korean J Intern Med; 2021 Mar; 36(Suppl 1):S196-S206. PubMed ID: 32241082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deubiquitinase USP13 promotes the epithelial-mesenchymal transition and metastasis in gastric cancer by maintaining Snail protein.
    Zhang T; Zheng J; Qiao L; Zhao W
    Pathol Res Pract; 2022 Jan; 229():153705. PubMed ID: 34872023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imatinib and nilotinib induce apoptosis of chronic myeloid leukemia cells through a Bim-dependant pathway modulated by cytokines.
    Belloc F; Moreau-Gaudry F; Uhalde M; Cazalis L; Jeanneteau M; Lacombe F; Praloran V; Mahon FX
    Cancer Biol Ther; 2007 Jun; 6(6):912-9. PubMed ID: 17538248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deubiquitinase USP13 dictates MCL1 stability and sensitivity to BH3 mimetic inhibitors.
    Zhang S; Zhang M; Jing Y; Yin X; Ma P; Zhang Z; Wang X; Di W; Zhuang G
    Nat Commun; 2018 Jan; 9(1):215. PubMed ID: 29335437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of MDM2 by nilotinib contributes to cytotoxicity in both Philadelphia-positive and negative acute lymphoblastic leukemia.
    Zhang H; Gu L; Liu T; Chiang KY; Zhou M
    PLoS One; 2014; 9(6):e100960. PubMed ID: 24968304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA damage, lysosomal degradation and Bcl-xL deamidation in doxycycline- and minocycline-induced cell death in the K562 leukemic cell line.
    Fares M; Abedi-Valugerdi M; Hassan M; Potácová Z
    Biochem Biophys Res Commun; 2015 Jul; 463(3):268-74. PubMed ID: 26022120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nilotinib enhances β-islets integrity and secretory functions in a rat model of STZ-induced diabetes mellitus.
    Samaha MM; Said E; Salem HA
    Eur J Pharmacol; 2019 Oct; 860():172569. PubMed ID: 31351037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Bcl-xL in paracetamol-induced tubular epithelial cell death.
    Lorz C; Justo P; Sanz AB; Egido J; Ortíz A
    Kidney Int; 2005 Feb; 67(2):592-601. PubMed ID: 15673306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ubiquitin specific protease-13 independently regulates parkin ubiquitination and alpha-synuclein clearance in alpha-synucleinopathies.
    Liu X; Hebron M; Shi W; Lonskaya I; Moussa CE
    Hum Mol Genet; 2019 Feb; 28(4):548-560. PubMed ID: 30329047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The selective tyrosine kinase-inhibitor nilotinib alleviates experimentally induced cisplatin nephrotoxicity and heptotoxicity.
    Ateyya H; Hassan ZA; El-Sherbeeny NA
    Environ Toxicol Pharmacol; 2017 Oct; 55():60-67. PubMed ID: 28826126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipopolysaccharide reduces USP13 stability through c-Jun N-terminal kinase activation in Kupffer cells.
    Yu F; Li Y; Ye Q; Miao J; Taleb SJ; Zhao Y; Zhao J
    J Cell Physiol; 2021 Jun; 236(6):4360-4368. PubMed ID: 33169399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.